Skip to main content

Identifying Opportunities to Block HIV-1 Transmission in the Female Genital Tract

  • Living reference work entry
  • Latest version View entry history
  • First Online:
Encyclopedia of AIDS

Definition

HIV-1 transmission is both inefficient and heterogeneous, and host factors that prevent and/or facilitate viral acquisition in HIV-uninfected individuals hold the key to better biomedical prevention. This review will highlight some of the factors influencing HIV transmission via the female genital tract.

Background to the Problem

HIV is predominantly transmitted during sexual intercourse (HIV-1 Sexual Transmission), with young women having the highest risk of HIV infection in parts of the world that are severely impacted by the pandemic (Abdool Karim et al. 2011b). Despite the size of the current HIV pandemic, HIV is relatively inefficient at infecting susceptible target cells across the genital mucosa of women, with estimated per-coital transmission rates as low as 1 per 1,000 contacts (Powers et al. 2008). This suggests that natural barriers to HIV infection within the mucosal surfaces of the female genital tract are generally effective. To gain entry via mucosal...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany AB, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D, CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168–74.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Abdool Karim SS, Kashuba AD, Werner L, Abdool KQ. Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women. Lancet. 2011a;378:279–81.

    Article  PubMed Central  Google Scholar 

  • Abdool Karim Q, Kharsany AB, Frohlich JA, Werner L, Mashego M, Mlotshwa M, Madlala BT, Ntombela F, Abdool Karim SS. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol. 2011b;40:922–30.

    Article  PubMed  PubMed Central  Google Scholar 

  • Abela IA, Berlinger L, Schanz M, Reynell L, Günthard HF, Rusert P, Trkola A. Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies. PLoS Pathog. 2012;8:e1002634.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Wald A, Corey L, Donnell D, Campbell MS, Mullins JI, Celum C. Partners in prevention HSV/HIV transmission study team. Sci Transl Med. 2011;3:77.

    Article  Google Scholar 

  • Cohen MS, Muessig KE, Smith MK, Powers KA, Kashuba AD. Antiviral agents and HIV prevention: controversies, conflicts, and consensus. AIDS. 2012;26:1585–98.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, Drummond DD, Legasse AW, Axthelm MK, Oswald K, Trubey CM, Piatak Jr M, Lifson JD, Nelson JA, Jarvis MA, Picker LJ. Effector memory T cell response are associated with protection of rhesus monkeys from mucosal simian immuno deficiency virus challenge. Nat Med. 2009;15:293–9.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Hansen SG, Sacha JB, Hughes CM, Ford JC, Burwitz BJ, Scholz I, Gilbride RM, Lewis MS, Gilliam AN, Ventura AB, Malouli D, Xu G, Richards R, Whizin N, Reed JS, Hammond KB, Fischer M, Turner JM, Legasse AW, Axthelm MK, Edlefsen PT, Nelson JA, Lifson JD, Früh K, Picker LJ. Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms. Science. 2013;340:1237874.

    Article  PubMed  Google Scholar 

  • Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, Evans DT, Montefiori DC, Karnasuta C, Sutthent R, Liao HX, DeVico AL, Lewis GK, Williams C, Pinter A, Fong Y, Janes H, DeCamp A, Huang Y, Rao M, Billings E, Karasavvas N, Robb ML, Ngauy V, de Souza MS, Paris R, Ferrari G, Bailer RT, Soderberg KA, Andrews C, Berman PW, Frahm N, De Rosa SC, Alpert MD, Yates NL, Shen X, Koup RA, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Rerks-Ngarm S, Michael NL, Kim JH. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med. 2012;366:1275–86.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Hessell AJ, Rakasz EG, Poignard P, Hangartner L, Landucci G, Forthal DN, Koff WC, Watkins DI, Burton DR. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers. PLoS Pathog. 2009;5:e1000433.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, Eschenbach D, McElrath MJ. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity. 2007;26:257–70.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, Ping LH, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A. 2008;105:7552–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Li Q, Estes JD, Schlievert PM, Duan L, Brosnahan AJ, Southern PJ, Reilly CS, Peterson ML, Schultz-Darken N, Brunner KG, Nephew KR, Pambuccian S, Lifson JD, Carlis JV, Haase AT. Glycerol monolaurate prevents mucosal SIV transmission. Nature. 2009;458:1034–8.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R, Buchbinder SP, Robertson MN, Mehrotra DV, Self SG, Corey L, Shiver JW, Casimiro DR, Step Study Protocol Team. HIV-1 vaccine-induced immunity in the test-of-concept step study: a case-cohort analysis. Lancet. 2008;372:1894–905.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8:553–63.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lyle R. McKinnon .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this entry

Cite this entry

McKinnon, L.R., Passmore, JA.S. (2014). Identifying Opportunities to Block HIV-1 Transmission in the Female Genital Tract. In: Hope, T., Stevenson, M., Richman, D. (eds) Encyclopedia of AIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9610-6_138-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9610-6_138-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Online ISBN: 978-1-4614-9610-6

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Identifying Opportunities to Block HIV-1 Transmission in the Female Genital Tract
    Published:
    30 September 2014

    DOI: https://doi.org/10.1007/978-1-4614-9610-6_138-1

  2. Original

    Inflammatory Cytokines
    Published:
    29 September 2014

    DOI: https://doi.org/10.1007/978-1-4614-9610-6_302-1